Location: Miami, FL
CIK: 0001937964 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value: $416M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | VERONA PHARMA PLC | 924,204 | $87.41M | 21.0% | $67.66 | — | SPONSORED ADS | 925050106 |
| INSM | INSMED INC | 752,712 | $75.75M | 18.2% | $72.29 | +5.8% | COM PAR $.01 | 457669307 |
| ARGX | ARGENX SE | 78,311 | $43.17M | 10.4% | $527.57 | — | SPONSORED ADR | 04016X101 |
| SLNO | SOLENO THERAPEUTICS INC | 494,424 | $41.42M | 10.0% | $48.81 | +53.3% | COM | 834203309 |
| LLY | ELI LILLY & CO | 30,700 | $23.93M | 5.8% | $826.69 | -6.4% | COM | 532457108 |
| BSX | BOSTON SCIENTIFIC CORP | 155,200 | $16.67M | 4.0% | $100.78 | +0.4% | COM | 101137107 |
| — | MERUS N V | 296,750 | $15.61M | 3.8% | $42.88 | — | COM | N5749R100 |
| DGX | QUEST DIAGNOSTICS INC | 81,717 | $14.68M | 3.5% | $165.04 | +4.3% | COM | 74834L100 |
| AZN | ASTRAZENECA PLC | 190,752 | $13.33M | 3.2% | $69.76 | — | SPONSORED ADR | 046353108 |
| — | VERONA PHARMA PLC | 91,800 | $8.682M | 2.1% | $67.66 | — | Put | 925050106 |
| XBI | SPDR SER TR | 100,000 | $8.293M | 2.0% | — | — | Put | 78464A870 |
| TRVI | TREVI THERAPEUTICS INC | 1,311,840 | $7.176M | 1.7% | $6.22 | 0.0% | COM | 89532M101 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 20,970 | $6.838M | 1.6% | $197.76 | +39.9% | COM | 02043Q107 |
| UGL | PROSHARES TR II | 168,000 | $5.823M | 1.4% | — | — | Call | 74347W601 |
| REGN | REGENERON PHARMACEUTICALS | 10,671 | $5.602M | 1.3% | $556.12 | 0.0% | COM | 75886F107 |
| SRRK | SCHOLAR ROCK HLDG CORP | 126,285 | $4.473M | 1.1% | $38.47 | -18.4% | COM | 80706P103 |
| INSM | INSMED INC | 40,000 | $4.026M | 1.0% | $72.29 | +5.8% | Call | 457669307 |
| RVMD | REVOLUTION MEDICINES INC | 104,190 | $3.833M | 0.9% | $48.13 | -20.2% | COM | 76155X100 |
| — | SPRINGWORKS THERAPEUTICS INC | 63,930 | $3.004M | 0.7% | $48.87 | — | COM | 85205L107 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 316,700 | $2.98M | 0.7% | $9.59 | -28.0% | COM NEW | 30233G209 |
| ABBV | ABBVIE INC | 14,500 | $2.691M | 0.6% | $182.67 | 0.0% | COM | 00287Y109 |
| VKTX | VIKING THERAPEUTICS INC | 96,479 | $2.557M | 0.6% | $28.19 | -6.6% | COM | 92686J106 |
| ASND | ASCENDIS PHARMA A/S | 12,240 | $2.113M | 0.5% | $159.57 | — | SPONSORED ADR | 04351P101 |
| TGTX | TG THERAPEUTICS INC | 54,515 | $1.962M | 0.5% | $28.70 | +29.7% | COM | 88322Q108 |
| VRTX | VERTEX PHARMACEUTICALS INC | 4,400 | $1.959M | 0.5% | $460.83 | 0.0% | COM | 92532F100 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 41,830 | $1.521M | 0.4% | $36.05 | 0.0% | COM | 90400D108 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 5,000 | $1.437M | 0.3% | $342.70 | -12.8% | COM | 91307C102 |
| MREO | MEREO BIOPHARMA GROUP PLC | 475,361 | $1.288M | 0.3% | $3.23 | — | SPON ADS | 589492107 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 22,951 | $1.269M | 0.3% | $36.55 | +31.3% | COM | 74366E102 |
| XENE | XENON PHARMACEUTICALS INC | 40,000 | $1.252M | 0.3% | $46.00 | -29.1% | COM | 98420N105 |
| BHVN | BIOHAVEN LTD | 80,000 | $1.129M | 0.3% | $17.82 | 0.0% | COM | G1110E107 |
| RNAM | AVIDITY BIOSCIENCES INC | 34,600 | $983K | 0.2% | $29.81 | 0.0% | COM | 05370A108 |
| KNSA | KINIKSA PHARMACEUTICALS INTL | 29,200 | $808K | 0.2% | $25.46 | 0.0% | ORD SHS CL A | G52694109 |
| MLYS | MINERALYS THERAPEUTICS INC | 41,100 | $556K | 0.1% | $14.49 | 0.0% | COM | 603170101 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 27,319 | $495K | 0.1% | $18.24 | 0.0% | ORDINARY SHARES | N62509109 |
| JANX | JANUX THERAPEUTICS INC | 20,000 | $462K | 0.1% | $52.89 | -50.2% | COM | 47103J105 |
| TVTX | TRAVERE THERAPEUTICS INC | 30,900 | $457K | 0.1% | $20.30 | -18.3% | COM | 89422G107 |